Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial

This study sought to report the treatment effect of ticagrelor on myocardial infarction (MI) and the strategy for and impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. - Background - In PLATO, ticagrelor reduced cardiovascular death, MI, or stroke in patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahaffey, Kenneth (Author) , Held, Claes (Author) , Wojdyla, Daniel M. (Author) , James, Stefan K. (Author) , Katus, Hugo (Author) , Husted, Steen (Author) , Steg, Philippe Gabriel (Author) , Cannon, Christopher P. (Author) , Becker, Richard C. (Author) , Storey, Robert F. (Author) , Khurmi, Nardev S. (Author) , Nicolau, José C. (Author) , Yu, Cheuk-Man (Author) , Ardissino, Diego (Author) , Budaj, Andrzej (Author) , Morais, Joao (Author) , Montgomery, Debra (Author) , Himmelmann, Anders (Author) , Harrington, Robert A. (Author) , Wallentin, Lars (Author)
Format: Article (Journal)
Language:English
Published: 19 February 2014
In: Journal of the American College of Cardiology
Year: 2014, Volume: 63, Issue: 15, Pages: 1493-1499
ISSN:1558-3597
DOI:10.1016/j.jacc.2014.01.038
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jacc.2014.01.038
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0735109714004562
Get full text
Author Notes:Kenneth W. Mahaffey, Claes Held, Daniel M. Wojdyla, Stefan K. James, Hugo A. Katus, Steen Husted, Philippe Gabriel Steg, Christopher P. Cannon, Richard C. Becker, Robert F. Storey, Nardev S. Khurmi, José C. Nicolau, Cheuk-Man Yu, Diego Ardissino, Andrzej Budaj, Joao Morais, Debra Montgomery, Anders Himmelmann, Robert A. Harrington, Lars Wallentin
Description
Summary:This study sought to report the treatment effect of ticagrelor on myocardial infarction (MI) and the strategy for and impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. - Background - In PLATO, ticagrelor reduced cardiovascular death, MI, or stroke in patients with acute coronary syndromes (ACS).
Item Description:Gesehen am 26.08.2020
Physical Description:Online Resource
ISSN:1558-3597
DOI:10.1016/j.jacc.2014.01.038